UnknownNot Applicable

Obesity-hypoventilation in Metabolic Syndrom Patients

France400 participantsStarted 2020-08-01

Plain-language summary

The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * BMI\>30 kg/m2 * no treatment with CPAP nor NIV Exclusion Criteria: * obstructive respiratory disease * non-treated cardiac dysfunction

What they're measuring

Capnia

Timeframe: Up to one mont after inclusion

Arterial pression in CO2

Timeframe: At the inclusion

Trial details

NCT IDNCT04839419

SponsorSOS Oxygene Mediterranee

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-08-01

Contact for this trial

Delphine Delample, PhD

0612155648 d.delample@sosoxygene.com

View on ClinicalTrials.gov More Metabolic Syndrome trials